Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Immunology

Understanding Your Granuloma Biopsies

At a Glance

In combined immunodeficiency with granulomas, a biopsy can show patterns that suggest infection but usually cannot identify the cause alone. Negative cultures or stains do not rule out infection, so PCR or sequencing may be needed to guide safer treatment.

When you or your child has combined immunodeficiency with granulomas, the appearance of granulomas—those firm, red-brown nodules—can be confusing. A biopsy is the primary tool doctors use to understand these lesions, but a standard “routine” pathology check may not be enough. In this condition, granulomas can have sterile inflammatory causes, or they may be the immune system’s way of trying to “wall off” an infectious threat it cannot completely destroy due to its genetic limitations [1][2].

Why Granulomas Form: The Search for a Trigger

In most people, the immune system identifies a germ, kills it, and moves on. In combined immunodeficiency, because the T-cell and B-cell “library” is restricted, the immune system might detect a germ but lack the specific “tools” to finish the job [3][4].

One important possibility in a subset of patients with primary immunodeficiency (particularly some RAG-related cases) is that these granulomas can be triggered by iVDRV (immunodeficiency-related vaccine-derived rubella virus) [5][1]. This is a strain of the rubella virus from the standard MMR vaccine. While the vaccine is safe for most children, in a person with a compromised immune system, the weakened virus can persist in the body for years, hiding inside cells and causing the immune system to form chronic granulomas in an attempt to contain it [6][7]. Other common infectious triggers include atypical mycobacteria and fungi. In some cases, no infectious trigger is ever found, and the granuloma is autoimmune or inflammatory in nature.

Why Routine Testing Often Misses the Mark

A “routine” biopsy usually involves two things: looking at the tissue under a microscope (histopathology) and trying to grow germs in a dish (culture) [8].

  • The Problem with Cultures: Many triggers, like the rubella vaccine strain or certain atypical mycobacteria, are notoriously difficult to grow in a lab. They may be present in the tissue but remain “culture-negative” [1][2].
  • The Problem with Stains: Standard stains (like AFB for tuberculosis) have low sensitivity. They often only show a positive result if there are a huge number of organisms present [8][9].

Advanced Testing: What to Ask For

To find a “hidden” cause of a granuloma, your medical team may need to use more advanced molecular techniques. You can ask your pathology and infectious-disease teams if the following tests are appropriate and how the results would change your treatment:

  • Metagenomic Next-Generation Sequencing (mNGS): Instead of looking for one specific germ, it sequences the DNA/RNA in a sample and compares it to a database of known viruses, bacteria, and fungi [10][1]. While it can help find the rubella vaccine virus, it is not a perfect “catch-all.” It is expensive, may not be available, can miss low-level organisms, and can sometimes detect contamination or non-viable DNA that doesn’t prove active disease.
  • Targeted PCR: If your doctor suspects a specific culprit—like the rubella virus or BCG (the tuberculosis vaccine)—they can use Polymerase Chain Reaction (PCR) to look for the genetic fingerprint of that specific organism [2][11].
  • 16S or ITS Sequencing: These are specialized molecular tests used specifically to identify bacteria (16S) or fungi (ITS) that won’t grow in a standard culture [12][13].

Understanding the Pathology Report

When the pathologist looks at the biopsy, the “pattern” of the granuloma provides clues, though they are supportive observations, not standalone diagnostic rules:

  • Tuberculoid/Necrotizing: These granulomas have a “dead” or “cheesy” center (necrosis). This pattern is frequently associated with an infectious trigger, such as a vaccine virus or mycobacteria [1][2].
  • Sarcoidal: These are “cleaner” granulomas without a dead center. While they can look like the common condition sarcoidosis, they should still be treated as potentially infectious until proven otherwise [14][15].
  • The CD4:CD8 Ratio: In classic sarcoidosis, the immune cells in the granuloma are usually dominated by CD4 T cells. In primary immunodeficiencies, the ratio can sometimes be flipped, with as many or more CD8 T cells (the “killer” cells) present [16][17]. However, this varies by specimen and method.

Identifying the specific trigger is critical because it changes the treatment. If the granuloma is caused by a persistent vaccine virus, using heavy immune-suppressing drugs alone might make the infection worse. Knowing the cause allows your doctors to target the virus while safely managing the inflammation [6].

Common questions in this guide

What can a biopsy reveal about a granuloma in combined immunodeficiency?
A biopsy can show the type of inflammation and whether the granuloma has a dead center called necrosis. These patterns can suggest an infection, but they do not identify the cause by themselves, so cultures and molecular tests may also be needed.
Can the MMR vaccine cause a granuloma in a child with immune deficiency?
In a small subset of people with primary immune deficiency, the weakened rubella virus used in the MMR vaccine can persist and contribute to chronic granulomas. This is not expected in most people, and testing of tissue is needed before linking a granuloma to vaccine-derived rubella.
Why can cultures and special stains be negative even when an infection is present?
Some bacteria, fungi, and vaccine-derived viruses are difficult to grow, and routine stains may detect organisms only when many are present. A negative culture or stain therefore does not always rule out infection, especially when immune defenses are impaired.
What advanced tests can look for a hidden infection in granuloma tissue?
Targeted PCR can search for a suspected organism, such as rubella virus or BCG. Metagenomic sequencing can look broadly for genetic material from viruses, bacteria, and fungi, while 16S and ITS sequencing focus on bacteria and fungi; results still need clinical interpretation because contamination or non-viable material can be detected.
What does the CD4-to-CD8 ratio mean in a granuloma biopsy?
The ratio describes the types of immune cells found in the granuloma. Classic sarcoidosis often has more CD4 cells, while some primary immunodeficiencies may show as many or more CD8 cells, but the result varies and is supportive rather than diagnostic.
Why is finding the cause of a granuloma important for treatment?
If a persistent vaccine virus or another infection is present, strong immune-suppressing treatment alone could allow it to worsen. Identifying the cause helps the medical team consider targeted treatment for the infection while managing inflammation safely.

Get notified when new evidence is published on Combined immunodeficiency with granulomatosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Case report: Rubella virus-induced cutaneous granulomas in a girl with atypical SCID caused by DCLRE1C gene mutations.

    Deng S, Rao S, Wang AR, Shi W

    Frontiers in genetics 2023; (14()):1115027 doi:10.3389/fgene.2023.1115027.

    PMID: 37007969
  2. 2

    Rubella-associated granuloma in a patient with a compound heterozygous RAG1 defect and review of the literature.

    Akarsu A, Sonmez G, Schiefer AI, et al.

    Immunologic research 2025; (73(1)):150 doi:10.1007/s12026-025-09711-9.

    PMID: 41139764
  3. 3

    Case Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders - Outcome After Hematopoietic Stem Cell Transplantation.

    Baumann U, Schulte JH, Groß JP, et al.

    Frontiers in immunology 2022; (13()):886540 doi:10.3389/fimmu.2022.886540.

    PMID: 35720367
  4. 4

    Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity.

    Groß M, Speckmann C, May A, et al.

    The Journal of allergy and clinical immunology 2022; (149(1)):388-399.e4 doi:10.1016/j.jaci.2021.05.007.

    PMID: 34033843
  5. 5

    Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies.

    Perelygina L, Chen MH, Suppiah S, et al.

    PLoS pathogens 2019; (15(10)):e1008080 doi:10.1371/journal.ppat.1008080.

    PMID: 31658304
  6. 6

    Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV Infection.

    Dutmer CM, Asturias EJ, Smith C, et al.

    Journal of clinical immunology 2015; (35(8)):754-60 doi:10.1007/s10875-015-0207-8.

    PMID: 26515615
  7. 7

    Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity.

    Perelygina L, Faisthalab R, Abernathy E, et al.

    Frontiers in immunology 2021; (12()):796065 doi:10.3389/fimmu.2021.796065.

    PMID: 35003119
  8. 8

    Diagnosis of granulomatous inflammation in thoracic small biopsies and fine needle aspiration specimens: a multi-institutional study.

    Archila LR, Abraham AE, Adeniran AJ, et al.

    Journal of the American Society of Cytopathology 2026; doi:10.1016/j.jasc.2026.06.003.

    PMID: 42399153
  9. 9

    Clinical Usefulness of PCR for Differential Diagnosis of Tuberculosis and Nontuberculous Mycobacterial Infection in Paraffin-Embedded Lung Tissues.

    Kim YN, Kim KM, Choi HN, et al.

    The Journal of molecular diagnostics : JMD 2015; (17(5)):597-604.

    PMID: 26163897
  10. 10

    Early Identification of Fungal and Mycobacterium Infections in Pulmonary Granulomas Using Metagenomic Next-Generation Sequencing on Formalin fixation and paraffin embedding tissue.

    Sun W, Dong Z, Zhou Y, et al.

    Expert review of molecular diagnostics 2022; (22(4)):461-468 doi:10.1080/14737159.2022.2052046.

    PMID: 35261303
  11. 11

    Mycobacterium marinum Infection: A Clinical Case Report and 5-Year Systematic Literature Review (2021-2025).

    Yang X, Chai S, Han Y, Wei A

    Clinical, cosmetic and investigational dermatology 2026; (19()):610975 doi:10.2147/CCID.S610975.

    PMID: 42639276
  12. 12

    Spontaneous Cranial Epidural Inflammatory Granuloma Mimicking Brain Tumor: A Case Report.

    Gwak HS, Chun JY, Han NY, et al.

    Brain tumor research and treatment 2025; (13(4)):158-163 doi:10.14791/btrt.2025.0027.

    PMID: 41218818
  13. 13

    Phellinus species: An emerging cause of refractory fungal infections in patients with X-linked chronic granulomatous disease.

    Haidar G, Zerbe CS, Cheng M, et al.

    Mycoses 2017; (60(3)):155-160 doi:10.1111/myc.12573.

    PMID: 27781311
  14. 14

    Challenging Mimickers in the Diagnosis of Sarcoidosis: A Case Study.

    El Jammal T, Jamilloux Y, Gerfaud-Valentin M, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(7)) doi:10.3390/diagnostics11071240.

    PMID: 34359324
  15. 15

    High Inborn Errors of Immunity Risk in Patients with Granuloma.

    Süleyman M, Serin O, Koçali B, et al.

    Journal of clinical immunology 2022; (42(8)):1795-1809 doi:10.1007/s10875-022-01342-1.

    PMID: 35980494
  16. 16

    Cutaneous granulomas in the setting of primary immunodeficiency: a report of four cases and review of the literature.

    Harp J, Coggshall K, Ruben BS, et al.

    International journal of dermatology 2015; (54(6)):617-25 doi:10.1111/ijd.12765.

    PMID: 25773292
  17. 17

    Cutaneous and systemic granulomatosis in ataxia-telangiectasia: a clinico-pathological study.

    Szczawińska-Popłonyk A, Olejniczak K, Tąpolska-Jóźwiak K, et al.

    Postepy dermatologii i alergologii 2020; (37(5)):760-765 doi:10.5114/ada.2020.100485.

    PMID: 33240017

This page is for informational purposes only and does not constitute medical advice. Your pathologist, immunologist, and infectious-disease specialist should interpret your biopsy and testing results and guide treatment.